Ambriz FR

Language: Spanish
References: 15
Page: 73-80
PDF size: 112.98 Kb.

ABSTRACT

The problems that exist in our country in the security of the transfusion chain affect every step in the recruitment, donor selection, and aseptic collection, screening tests, production of blood components, storage, transportation and transfusion to recipient. Some of which can lead to fatal cases or moving slowly because of the fragmentation of our health system. With the principles of ethics, we must move towards a unified national blood system overcoming the conflicts of interest that affect the impact on administrative certifications; decrease the irrational use of resources, optimize costs and achieve a transfusion medicine security system and haemovigilance of the at the hospital. There has to be some regional blood banks well-coordinated in health institutions, with central management systems of quality and more specialized procedures, the latter can be achieved with more than 150 public blood banks, transforming them into positions of blood collection of voluntary donation of repetition. The resources would be released equip regional banks. Also required to provide education and legislation ad hoc for goals in voluntary blood donation and focused mainly the university population and centralize information for haemovigilance based computer systems specific hospitals, that reduce errors and restrict risk blood components involved in fatal cases, and reduce the possibility of punitive actions. It has international advice of the whole transfusion chain.

REFERENCES

1. Ambriz FR. Editorial. Presidente AMMTAC 2002-2004. Gac Méd Méx. 2003;139(Suppl):1.

2. Bosch MLA. Un análisis crítico de quién y cuándo transfundimos. Rev Mex Med Tran. 2010;3:22-9.

3. Cruz REA. Autoexclusión confidencial inefectiva en donadores de sangre y factores asociados. Patol Clin. 1999;46:147-50.

4. Contreras M. Current risk associated with allogeneic blood transfusion. Gac Méd Méx. 2004;140:71-2.

5. Rodríguez Moyado H. Enfermedades infecciosas por transfusión en México. Rev Mex Med Tran. 2011;4:78-90.

6. Rivera LMRF, Ambriz FR, Montes de Oca AE, Villegas MMR, Islas BMS. Contaminación bacteriana de hemocomponentes. Rev Mex Med Patol Clin. 2011;58:151-5.

7. Ambriz FR. Nuestros esfuerzos permiten nuestras fortalezas al año 2007 en el Banco Central de Sangre CMN Siglo XXI. Gac Méd Méx. 2007; 143:77-90.

8. Ambriz FR. Papel del banco de sangre en trasplantes. Rev Mex Med Tran. 2009;2:47-52.

9. Ambriz FR, García-Loera A, Rivera LR, et al. Apheresis impact on the supply of platelet components in Southern Mexico City. Vox Sang. 2010;99:169.

10. Ambriz LR, Rivera LR, García LA, Bonilla ZR, Betancourt L. «Justo a tiempo» para disminuir el tiempo de espera en los donadores de sangre en el año 2011. Una contribución original con métodos automatizados y aumento de la competitividad en una institución pública. Rev Mex Med Tran. 2012;5:6-18.

11. Ambriz FR. El enfoque para vencer la resistencia a la hemovigilancia. Rev Mex Patol Clin. 2009;56:2009-10.

12. Mejía DAM. Importancia clínica de la hemovigilancia, la gestión de la seguridad transfusional y de la hemovigilancia. Rev Mex Med Tran. 2009;2:90-4.

13. Sainderber E, Petraszko T, Senple E, Branch DR. Transfusion-related acute lung injury (TRALI). A Canadian blood services research and development symposium. Transfus Med Rev. 2010;24:305-24.

14. Eder F, Dy B, Rambaud M, Benjamin RJ. The residual risk of TRALI in a large U.S. blood system reflects the ongoing reliance on AB plasma from female donors to meet demand. Vox Sang. 2012;103 Suppl 1:20.

15. Contreras M, Martínez, Larrondo M, Cárdenas BC. The steps taken to establishing a blood service in Chile. ISBT Sci Ser. 2012;7:10-1.